Getinge (GNGBY) Stock Price, News & Analysis

Company Overview

Getinge AB is a Sweden-based medical technology company that develops products and solutions for hospitals, healthcare providers and life science organizations. Founded in 1904 in Getinge, Sweden, the company serves customers through operations and sales channels across Europe, North America, Asia-Pacific and other international markets.

Getinge organizes its business around Acute Care Therapies, Life Science and Surgical Workflows. Its offerings include ventilators, anesthesia systems, patient monitoring and cardiovascular support technologies, as well as equipment used in intensive care and other acute-care settings. The company also provides operating-room products such as surgical tables, lights, ceiling supply units and workflow and room-integration solutions.

Within its Life Science business, Getinge supplies sterilizers, washers, isolators, laboratory and cleanroom equipment, bioreactor systems and related solutions used in pharmaceutical manufacturing, biotechnology and research. The company also provides services, consumables and technical support for its equipment. Getinge is headquartered in Gothenburg, Sweden, and has been led by President and Chief Executive Officer Mattias Perjos since 2017.

Key Stats

• Today's Range: $24.24 to $24.30
• 50-Day Range: $20.61 to $25.80
• 52-Week Range: $18.99 to $25.98
• Volume: 3,607 shs
• Average Volume: 3,061 shs
• Market Capitalization: $6.60 billion
• P/E Ratio: 23.09
• Dividend Yield: 1.20%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Getinge Stock Analysis - MarketRank™

Getinge scored higher than 43% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Getinge has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 1 strong buy rating, no buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Getinge has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 6.52%

Earnings Growth

Earnings for Getinge are expected to grow by 6.52% in the coming year, from $1.38 to $1.47 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Getinge is 23.09, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.86.

Price to Earnings Ratio vs. Sector

The P/E ratio of Getinge is 23.09, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.06.

Price to Book Value per Share Ratio

Getinge has a P/B Ratio of 2.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Getinge has been sold short.

Short Interest Ratio / Days to Cover

Getinge has a short interest ratio ("days to cover") of 0.35, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Getinge has recently increased by 0.35%, indicating that investor sentiment is decreasing.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Getinge pays a meaningful dividend of 1.18%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Getinge does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Getinge is 27.62%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Getinge will have a dividend payout ratio of 19.73% next year. This indicates that Getinge will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Getinge this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Getinge insiders have not sold or bought any company stock.

Percentage Held by Institutions

Getinge has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 7/17/2026
• Today: 9/16/2026
• Next Earnings (Estimated): 10/20/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:GNGBY
• CIK: N/A
• Web: www.getinge.com
• Phone: (610) 335-0000
• Fax: 46-1-033-556-40
• Employees: 11,670
• Year Founded: 1904

Profitability

• EPS (Trailing Twelve Months): $1.05
• Trailing P/E Ratio: 23.09
• Forward P/E Ratio: 17.57
• P/E Growth: N/A
• Net Income: $230.87 million
• Net Margins: 7.81%
• Pretax Margin: 10.73%
• Return on Equity: 11.12%
• Return on Assets: 5.88%

Debt

• Debt-to-Equity Ratio: 0.26
• Current Ratio: 1.31
• Quick Ratio: 0.74

Sales & Book Value

• Annual Sales: $3.57 billion
• Price / Sales: 1.85
• Cash Flow: $1.98 per share
• Price / Cash Flow: 12.22
• Book Value: $11.07 per share
• Price / Book: 2.19

Miscellaneous

• Outstanding Shares: 272,370,000
• Free Float: N/A
• Market Cap: $6.60 billion
• Optionable: Not Optionable
• Beta: 0.93